FHI
Generic Name: fenofibrate
Pill imprint FHI has been identified as Fenoglide 120 mg.
Fenoglide is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Fenoglide 120 mg is not subject to the Controlled Substances Act.
See also related documents.
Fenoglide Images
- Generic Name:
- fenofibrate
- Imprint:
-
FHI
- Strength:
- 120 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sciele Pharma Inc.
- National Drug Code (NDC):
- 59630-0495
Advertisement
More Fenoglide resources
Search Again
